9/15/2020 8:11:14 AM
Gilead Sciences: FDA Grants Breakthrough Therapy Designation For Magrolimab For Myelodysplastic Syndrome
9/4/2020 8:33:43 AM
Kite Submits SBLA To FDA For Yescarta In Relapsed Or Refractory Indolent Non-Hodgkin Lymphomas
9/3/2020 8:03:39 AM
Kite And HiFiBiO Therapeutics Enter 2-year Research Collaboration And License Agreement In Acute Myeloid Leukemia
9/1/2020 8:34:58 AM
Gilead Sciences And Jounce Therapeutics Announce License Deal
for Novel Immunotherapy Program
8/25/2020 2:11:11 AM
Gilead Presents Over 40 Abstracts From Extensive Liver Disease Programs At Digital International Liver Congress 2020
8/19/2020 12:36:48 AM
Galapagos: Gilead Sciences Receives CRL From FDA For NDA For Filgotinib
8/17/2020 4:08:03 PM
Gilead Sciences And Tango Therapeutics To Expand Strategic Oncology Collaboration
8/11/2020 8:15:09 AM
Gilead Sciences Says China NMPA Approved Pre-exposure Prophylaxis Indication For Truvada
8/10/2020 11:04:49 AM
Gilead Submits NDA To FDA For Remdesivir For Treatment Of COVID-19